The purpose of the company, as part of the BridgeBio group, is the exploitation, development, production, distribution and marketing of pharmaceuticals. The company may establish branches and subsidiaries at home and abroad and acquire, manage and dispose of participations. The company may acquire, hold and dispose of real estate as well as patent, trademark, copyright, design and all other intellectual property rights at home and abroad. The company may provide management services for affiliated companies. The company may undertake and/or avail itself of financing of any kind for its own or third-party account and in particular enter into credit or security transactions (including the granting of pledges, security assignments and transfers, guarantees, sureties, comfort letters, indemnity obligations and economic advantages related to such transactions), for a fee or free of charge, with, in favor of and/or in relation to liabilities of direct or indirect shareholders, subsidiaries and other affiliated companies, even if such financings, credit or security transactions are exclusively in the interest of direct or indirect shareholders and/or affiliated companies. The company may engage in any other transactions and take measures that appear suitable to promote the purpose of the company or are directly or indirectly related thereto.
Outbound Leads by COHAGA